Homologous recombination deficiency (HRD) score in aggressive prostatic adenocarcinoma with or without intraductal carcinoma of the prostate (IDC-P).

BMC Med · 2022 · PMC9306093 · PMID 35864546

Europe PMC DOI

hedged sentence

0.0760

closest p · 1.5× alpha

0.0760

boldest claim

The sentences

borderline significanceP =0.076so close (0.05 < p ≤ 0.1)

10.0; P =0.009), while HRD-TAI score showed a borderline significance (median: 3.0 vs. 2.0, P =0.076).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.